Haemonetics (NYSE:HAE) Rating Increased to Strong-Buy at Baird R W
Baird R W upgraded shares of Haemonetics (NYSE:HAE – Free Report) to a strong-buy rating in a research report sent to investors on Wednesday morning,Zacks.com reports. Other equities research analysts have also issued research reports about the stock. Robert W. Baird started coverage on shares of Haemonetics in a research note on Thursday. They set […]
More Stories
Wells Fargo & Company Lowers Lamar Advertising (NASDAQ:LAMR) Price Target to $119.00
Lamar Advertising (NASDAQ:LAMR – Get Free Report) had its target price reduced by research analysts at Wells Fargo & Company...
Wheaton Precious Metals (NYSE:WPM) PT Set at $106.00 by UBS Group
Wheaton Precious Metals (NYSE:WPM – Get Free Report) received a $106.00 price objective from analysts at UBS Group in a...
lululemon athletica (NASDAQ:LULU) Given New $260.00 Price Target at Robert W. Baird
lululemon athletica (NASDAQ:LULU – Get Free Report) had its target price lowered by analysts at Robert W. Baird from $340.00...
JD.com (NASDAQ:JD) Earns Buy Rating from Analysts at Citigroup
Investment analysts at Citigroup started coverage on shares of JD.com (NASDAQ:JD – Get Free Report) in a research report issued...
Citigroup Raises Zymeworks (NYSE:ZYME) Price Target to $22.00
Zymeworks (NYSE:ZYME – Get Free Report) had its target price increased by Citigroup from $19.00 to $22.00 in a research...
Adobe (NASDAQ:ADBE) Rating Lowered to “Sell” at Melius
Adobe (NASDAQ:ADBE – Get Free Report) was downgraded by stock analysts at Melius from a “hold” rating to a “sell”...